Preferred Label : tasimelteon;

MeSH note : structure in first source;

CISMeF synonym : BMS 214778;

MeSH synonym : N-((2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)propanamide;

MeSH hyponym : BMS214778; BMS-214778;

Is substance : O;

UNII : SHS4PU80D9;

InChIKey : PTOIAAWZLUQTIO-GXFFZTMASA-N;

Details


Main resources

You can consult :


https://www.ema.europa.eu/medicines/human/EPAR/Hetlioz
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
tasimelteon
tasimelteon
receptors, melatonin
adult
Persons with Visual Disabilities
Non-24 hour Sleep-Wake disorder
orphan drug production
administration, oral
drug monitoring
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
Product containing melatonin agonist (product)
drug evaluation, preclinical
tasimelteon
Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule (clinical drug)
sleep disorders, circadian rhythm
benzofurans
cyclopropanes
benzofurans
cyclopropanes

---
Nous contacter.
25/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.